Page 59 - Read Online
P. 59

[Table 3]. On univariate analysis, patients with tumor size   Table 3: Univariate analysis of factors related to “one-off”
           ≤ 3 cm had a higher rate of achieving “one-off ” ablation   radiofrequency ablation
           than those with tumor size > 3 cm (92.0% vs. 85.3%, P   Variables  Achieved    Failed        P
           = 0.003), while tumor close to the organs had a lower            (n = 281) (%)  (n = 181) (%)
           rate of achieving “one-off ” ablation than those further   Sex   221 (59.2)    152 (40.8)    0.156
                                                               Male
           from organs (50.8% vs. 64.2%, P = 0.010). On multivariate   Female  60 (67.4)  29 (32.6)
           analysis using a logistic regression, tumor size ≤ 3 cm   Age
           [odds ratio (OR), 0.534; 95% confidence interval (CI):   ≤ 60    180 (59.2)    125 (40.8)    0.268
                                                               > 60
           0.346-0.825, P = 0.005] and tumor further from organs   PLT (×10 /L)  101 (64.3)  56 (35.7)  0.119
                                                                            143.0 ± 57.9
                                                                                          119.2 ± 54.6
                                                                    9
           (OR, 0.593; 95% CI: 0.387-0.909,  P = 0.017) remained   PT (s)   12.2 ± 0.98   12.4 ± 0.93   0.533
           predictive for the success of “one-off ” RFA [Table 4].  Bilirubin (µmol/L) 17.8 ± 14.3  16.7 ± 6.1  0.713
                                                              Albumin (g/L)  41.2 ± 4.2   41.4 ± 4.0    0.857
           DISCUSSION                                         Prealbumin (mg/  189.5 ± 54.9  183.8 ± 50.1    0.687
                                                              dL)
                                                              ALT (IU/L)    94.8 (9.40, 546.80) 70.2 (18.10, 154.80) 0.710
                                                      [14]
           RFA, a newly developed local ablative technique,  is   AFP (ng/dL)
           suggested by AASLD and the European Association for   ≤ 400      225 (60.3)    148 (39.7)    0.652
           the Study of the Liver (EASL) as the first-line treatment   > 400  56 (62.9)   33 (37.1)
           for HCC due to its safety, lower mortality and morbidity,   Child-Pugh
                                                              classification
           and shorter hospitalization.  “One-off ” ablation, first   Class A  267 (60.4)  175 (39.6)   0.390
                                   [15]
           proposed by Jiang et al., [9-11]  defined as (1) the diameter   Class B  14 (70.0)  6 (30.0)
           of post-RFA zone demonstrated by contrast-enhanced   Hepatitis
           CT is more than the maximal length of the tumor, and   background              140 (40.7)    0.253
                                                               HBV and/or HCV 204 (59.3)
           (2) no tumor recurrence within 6 months after RFA.   None        77 (65.3)     41 (34.7)
           However, not all tumors can achieve “one-off ” ablation   HBsAg
           after a single-session RFA. So far, numerous investigators   Present  197 (59.2)  136 (40.8)    0.239
                                                               Absent
                                                                                          45 (34.9)
                                                                            84 (65.1)
           have described prognostic factors for survival after RFA.   HBeAg
           However, no large study has illustrated the predictive   Present  67 (57.2)    50 (42.7)     0.362
           factors for the success of “one-off ” ablation after a single-  Absent  214 (62.0)  131 (38.0)
           session RFA. In the study, we focused on the analyses of   Tumor size (cm)  184 (92.0)  142 (8.0)  0.003
                                                               ≤ 3.0
           the effectiveness of single-session RFA in single HCC, and   > 3.0  97 (85.3)  39 (14.7)
           investigated the risk factors influencing the success of   Tumor location
           “one-off ” ablation to provide clinicians a guideline for   Parenchyma  181 (59.0)  126 (41.0)  0.248
                                                               Sub-capsular
           their routine medical treatments.                  Close to organs  100 (64.5)  55 (35.5)
                                                               Yes          60 (50.8)     58 (49.2)     0.010
           Our study showed that tumors measuring 3 cm in      No           221 (64.2)    123 (37.8)
           greatest dimension and which are further to organs were   Close to blood
           most suitable for a single-session, single application of   vessels  25 (62.5)  15 (37.5)    0.820
                                                               Yes
           percutaneous RFA [Table 3]. As reported, when RFA was   No       256 (60.1)    166 (39.3)
           performed  on  small  HCC  nodules  (≤  3  cm),  complete   PLT: platelet; PT: prothrombin time; ALT: alanine aminotransferase;
                                                         [16]
           necrosis can be achieved in more than 90% patients.    AFP: alpha fetal protein; HBV: hepatitis B virus; HCV: hepatitis C
           As the tumor size increased, the therapeutic effect of   virus; HBsAg: hepatitis B surface antigen; HBeAg: hepatitis B e
           RFA decreased. For tumors 3.0-5.0 cm and tumors larger   antigen
           than 5.0 cm, complete tumor necrosis rates was 71% and   Table 4: Multivariate analysis of factors related to “one-off”
           45%, respectively.  In this study, the mean tumor size is   radiofrequency ablation
                          [17]
           2.6 ± 1.1 cm. The primary effectiveness was 90.0% and   Variables             OR    95% CI   P
           the rate of “one-off ” ablation in our study was 60.8%.   Tumor size (≤ 3 cm vs. > 3 cm)  0.534   0.346-0.825 0.005
                                                              Tumor close to organs (no vs. yes)
           Patients with tumor size ≤ 3 cm had a higher rate to   OR: odds ratio; CI: confidence interval 0.593 0.387-0.909   0.017
           achieve “one-off ” ablation than those with tumor size
           > 3 cm, similar to observations by Komorizono et al.    that the cirrhotic tissue around small HCC behaved
                                                         [18]
           Komorizono’s study showed that tumors measuring ≤ 2   like a thermal insulator, increasing the heat retention
           cm in greatest dimension were indicated for an optimal   within the tumor and preventing heating outside the
           ablation.  Tumor size may influence the success of “one-  tumor. However, when the tumor is > 3 cm, heat may
                   [18]
                                                                                                       [19]
           off ” RFA due to three possible reasons: first, RFA induced   be lost in the periphery. Meanwhile, Ahmed et al.  used
           tumor coagulative necrosis by putting high-frequency   an  established computer  simulation model of RFA to
           alternating  electrodes  within  the  tumor  tissue.  The   characterize the combined effects of varying perfusion,
           temperature inside the ablated tissue must be > 60 °C to   electrical, and thermal conductivity on radiofrequency
           achieve coagulation necrosis. Some authors suggested   (RF) heating. They observed that electrical and thermal

            50                                                    Hepatoma Research | Volume 2 | Issue 2 | February 29, 2016
   54   55   56   57   58   59   60   61   62   63   64